FDA Approves ‘Breakthough’ Drug to Prevent HIV
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient form of pre-exposure prophylaxis (PrEP). In clinical trials, the drug was shown to be highly effective at preventing HIV infection when taken just twice a year. At the same time, advocates are urging Gilead and U.S. officials to ensure the drug is widely accessible to the public. “PrEP is one of